This book investigates the application of nanostructured drug delivery systems for combating infectious diseases. It begins by outlining the global burden of infectious diseases, followed by a focused examination of the impact of viruses like COVID-19, Zika, and Ebola. The core of the book details various novel nanotherapeutic strategies for delivering drugs against viral, bacterial, and fungal infections, aiming to provide targeted and efficient treatment solutions.

The book is positioned as a valuable resource for graduates, researchers, and industry professionals engaged in infectious disease treatment and drug delivery. Its comprehensive scope, covering both the global burden of diseases and specific nanomedical strategies, suggests it aims to bridge the gap between fundamental research and practical application. The inclusion of recent viral outbreaks like COVID-19 indicates a focus on current and emerging challenges in the field. The detailed exploration of nanotherapeutic approaches promises to equip readers with knowledge for developing more efficient and targeted treatments.